(Q33608167)

28 July 2017

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study (English)

1 reference

28 July 2017

0 references

1 reference

15

R A Lothe

1 reference

28 July 2017

6

A Nesbakken

1 reference

28 July 2017

19

J Guinney

1 reference

28 July 2017

11

C Rosty

2 references

ORCID Public Data File 2021

28 July 2017

13

S R Alberts

1 reference

28 July 2017

R Dienstmann

1

1 reference

28 July 2017

M J Mason

2

1 reference

28 July 2017

F A Sinicrope

3

1 reference

28 July 2017

A I Phipps

4

1 reference

28 July 2017

S Tejpar

5

1 reference

28 July 2017

S A Danielsen

7

1 reference

28 July 2017

A Sveen

8

1 reference

28 July 2017

D D Buchanan

9

1 reference

28 July 2017

M Clendenning

10

1 reference

28 July 2017

B Bot

12

1 reference

28 July 2017

J Milburn Jessup

14

1 reference

28 July 2017

M Delorenzi

16

1 reference

28 July 2017

P A Newcomb

17

1 reference

28 July 2017

D Sargent

18

1 reference

28 July 2017

1 May 2017

1 reference

28 July 2017

1 reference

28 July 2017

28

1 reference

28 July 2017

5

1 reference

28 July 2017

1023-1031

1 reference

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

The consensus molecular subtypes of colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Association between molecular subtypes of colorectal cancer and patient survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Colorectal cancer statistics, 2014.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Predicting survival after curative colectomy for cancer: individualizing colon cancer staging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Toward evidence-based medical statistics. 2: The Bayes factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5406760

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

21 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX052

Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX052

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX052

Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX052

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX052

Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28453697

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/ANNONC/MDX052

1 reference

28 July 2017

1 reference

28 July 2017

1 reference